When Cells Run Low on Energy, They Don’t Just Slow Down — They Make a Decision

What a new study reveals about senescence, mitochondria, and recovery failure

Recent work published in iScience by Akakura and Tabibzadeh (2026) delivers a striking message: cellular senescence is not simply the end result of accumulated damage—it is an active, regulated decision that emerges when bioenergetic buffering collapses.

Even more importantly, the study shows that this decision can be reversible, provided key metabolic–epigenetic supports remain intact.

This finding resonates strongly with the core ideas behind Exposure-Related Malnutrition (ERM)—the concept that chronic stress, toxic exposure, inflammation, or disease can quietly erode recovery capacity long before overt deficiency or irreversible disease appears.

The key insight: impaired mitochondria don’t equal failure—until buffering breaks

Cells often operate with impaired oxidative phosphorylation (OXPHOS) due to stress, aging, or damage. Yet the study shows that cells can remain viable and adaptive as long as the TCA cycle is kept running. The critical factor is the availability of α-ketoglutarate (AKG), a central TCA intermediate.

AKG plays two essential roles at once:

1. Bioenergetic buffering

   AKG sustains TCA cycle continuity through anaplerotic pathways, allowing cells to generate ATP and manage redox balance even when mitochondrial efficiency is compromised.

   
   

2. Epigenetic plasticity

   AKG is required for TET enzymes that regulate DNA demethylation. This keeps transcriptional programs flexible and allows cells to adapt rather than lock into rigid stress states.

As long as AKG-dependent buffering is preserved, cells enter what the authors reveal as a constrained but adaptive “gridlock” state—metabolically inefficient, biased toward glycolysis and lipid storage, but still reversible.

When AKG collapses, the cell crosses a point of no return

The study demonstrates something crucial: disrupting AKG availability alone is sufficient to push cells into senescence.

When AKG–TET coupling fails, cells experience:

• Rising oxidative stress and DNA damage

• Loss of NAD⁺ balance and ATP availability

• Epigenetic “freezing” of stress-response programs

• Activation of inflammatory senescence signaling (SASP)

• Permanent exit from the cell cycle

At this point, senescence is no longer a gradual drift—it becomes a protective fate decision, likely evolved to prevent cancerous proliferation under conditions where energetic and epigenetic stability can no longer be guaranteed.

Yet remarkably, the authors also show that restoring AKG–TET activity can reverse senescence, even in aged human cells—as long as intervention occurs before structural lock-in.

Why this matters for ERM

ERM proposes that many chronic conditions are driven not by lack of intake, but by failure of recovery under sustained bioenergetic strain. This study provides a molecular backbone for that idea.

Within the ERM framework:

• Epigenetic gridlock corresponds to early-stage, subclinical ERM

• AKG depletion marks the transition from reversible adaptation to entrenched dysfunction

• Senescence represents the biological boundary where recovery is no longer energetically permitted

In other words, ERM is not about calories—it’s about whether mitochondria and metabolism still have room to maneuver.

Looking ahead: from theory to translation

This work opens several exciting translational possibilities:

• Early detection

  Biomarkers linked to AKG availability, NAD⁺ balance, redox load, and metabolic inflexibility could help identify ERM before irreversible decline.

  
  

• Recovery-centered interventions

  Strategies that reduce mitochondrial congestion (sleep, time-restricted eating, stress resolution, movement) and restore metabolic substrates may preserve reversibility.

  
  

• Future mitochondrial therapies

  Targeting AKG–TET coupling, mitochondrial throughput, and epigenetic plasticity could become central to geromedicine and chronic disease prevention.

A reframing worth remembering

You’re not broken—you’re exhausted.

This study reinforces a hopeful message: cells don’t fail suddenly; they adapt until they can’t. Understanding where that threshold lies—and how to support recovery before it’s crossed—may be one of the most powerful tools we have for extending healthspan.

If ERM is the clinical language of recovery failure, this study provides its molecular grammar.

Akakura, S., & Tabibzadeh, S. (2026). AKG–TET axis is central to senescence plasticity. iScience, 29, 114298. https://doi.org/10.1016/j.isci.2025.114298